These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
732 related articles for article (PubMed ID: 6423665)
1. Unidirectional transfer of prostaglandin endoperoxides between platelets and endothelial cells. Schafer AI; Crawford DD; Gimbrone MA J Clin Invest; 1984 Apr; 73(4):1105-12. PubMed ID: 6423665 [TBL] [Abstract][Full Text] [Related]
2. Synthesis of prostacyclin from platelet-derived endoperoxides by cultured human endothelial cells. Marcus AJ; Weksler BB; Jaffe EA; Broekman MJ J Clin Invest; 1980 Nov; 66(5):979-86. PubMed ID: 6776148 [TBL] [Abstract][Full Text] [Related]
3. Platelet interaction with vascular smooth muscle in synthesis of prostacyclin. Hechtman DH; Kroll MH; Gimbrone MA; Schafer AI Am J Physiol; 1991 May; 260(5 Pt 2):H1544-51. PubMed ID: 1903602 [TBL] [Abstract][Full Text] [Related]
4. Evidence for a bidirectional prostaglandin endoperoxide shunt between platelets and the bovine coronary artery. Mayeux PR; Kadowitz PJ; McNamara DB Biochim Biophys Acta; 1989 Mar; 1011(1):18-24. PubMed ID: 2493809 [TBL] [Abstract][Full Text] [Related]
5. Interactions between stimulated platelets and endothelial cells in vitro. Marcus AJ; Broekman MJ; Weksler BB; Jaffe EA; Safier LB; Ullman HL; Tack-Goldman K Philos Trans R Soc Lond B Biol Sci; 1981 Aug; 294(1072):343-53. PubMed ID: 6117896 [TBL] [Abstract][Full Text] [Related]
6. Cell-cell interaction between platelets and IL-1 beta-stimulated vascular smooth muscle cells in synthesis of thromboxane A2. Zou M; Anges C Prostaglandins Leukot Essent Fatty Acids; 1997 Feb; 56(2):85-91. PubMed ID: 9051715 [TBL] [Abstract][Full Text] [Related]
7. Effect of OKY-046, a thromboxane A2 synthetase inhibitor, on arachidonate-induced platelet aggregation: possible role of "prostaglandin H2 steal" mechanism. Kuzuya T; Hoshida S; Yamagishi M; Ohmori M; Inoue M; Kamada T; Tada M Jpn Circ J; 1986 Nov; 50(11):1071-8. PubMed ID: 3102802 [TBL] [Abstract][Full Text] [Related]
8. Familial bleeding tendency with partial platelet thromboxane synthetase deficiency: reorientation of cyclic endoperoxide metabolism. Defreyn G; Machin SJ; Carreras LO; Dauden MV; Chamone DA; Vermylen J Br J Haematol; 1981 Sep; 49(1):29-41. PubMed ID: 6268139 [TBL] [Abstract][Full Text] [Related]
9. Influence of selective thromboxane synthetase blocker CGS-13080 on thromboxane and prostacyclin biosynthesis in whole blood: evidence for synthesis of prostacyclin by leukocytes from platelet-derived endoperoxides. Mehta J; Mehta P; Lawson DL; Ostrowski N; Brigmon L J Lab Clin Med; 1985 Sep; 106(3):246-52. PubMed ID: 3928780 [TBL] [Abstract][Full Text] [Related]
10. A possible role of thromboxane A2 (TXA2) and prostacyclin (PGI2) in circulation. Gryglewski RJ; Dembínska-Kieć A; Korbut R Acta Biol Med Ger; 1978; 37(5-6):715-23. PubMed ID: 369254 [TBL] [Abstract][Full Text] [Related]
11. Substrate for endothelial prostacyclin production in the presence of platelets exposed to collagen is derived from the platelets rather than the endothelium. Chesterman CN; Owe-Young R; Macpherson J; Krilis SA Blood; 1986 Jun; 67(6):1744-50. PubMed ID: 3085750 [TBL] [Abstract][Full Text] [Related]
12. Platelet and blood vessel arachidonate metabolism and interactions. Needleman P; Wyche A; Raz A J Clin Invest; 1979 Feb; 63(2):345-9. PubMed ID: 372240 [TBL] [Abstract][Full Text] [Related]
13. Effects of thromboxane synthetase inhibition on arachidonate metabolism and platelet behaviour. Parry MJ Br J Clin Pharmacol; 1983; 15 Suppl 1(Suppl 1):23S-29S. PubMed ID: 6401997 [TBL] [Abstract][Full Text] [Related]
14. Aspirin-induced decline in prostacyclin production in patients with coronary artery disease is due to decreased endoperoxide shift. Analysis of the effects of a combination of aspirin and n-3 fatty acids on the eicosanoid profile. Force T; Milani R; Hibberd P; Lorenz R; Uedelhoven W; Leaf A; Weber P Circulation; 1991 Dec; 84(6):2286-93. PubMed ID: 1959184 [TBL] [Abstract][Full Text] [Related]
15. Thromboxane A2, prostacyclin and aspirin: effects on vascular tone and platelet aggregation. Smith JB; Araki H; Lefer AM Circulation; 1980 Dec; 62(6 Pt 2):V19-25. PubMed ID: 7002350 [TBL] [Abstract][Full Text] [Related]
16. Redirection of prostaglandin endoperoxide metabolism at the platelet-vascular interface in man. Nowak J; FitzGerald GA J Clin Invest; 1989 Feb; 83(2):380-5. PubMed ID: 2643628 [TBL] [Abstract][Full Text] [Related]
17. Effects of dipyrone on prostaglandin production by human platelets and cultured bovine aortic endothelial cells. Eldor A; Polliack G; Vlodavsky I; Levy M Thromb Haemost; 1983 Apr; 49(2):132-7. PubMed ID: 6346571 [TBL] [Abstract][Full Text] [Related]
18. Inhibition of prostacyclin by treatment of endothelium with aspirin. Correlation with platelet adherence. Czervionke RL; Smith JB; Fry GL; Hoak JC; Haycraft DL J Clin Invest; 1979 May; 63(5):1089-92. PubMed ID: 376548 [TBL] [Abstract][Full Text] [Related]
19. Cultured endothelial cells increase their capacity to synthesize prostacyclin following the formation of a contact inhibited cell monolayer. Eldor A; Vlodavsky I; Hy-Am E; Atzmon R; Weksler BB; Raz A; Fuks Z J Cell Physiol; 1983 Feb; 114(2):179-83. PubMed ID: 6401744 [TBL] [Abstract][Full Text] [Related]